Dr Bee Yong Mong
Head and Senior Consultant, Department of Endocrinology, Singapore General Hospital;Vice-President, Diabetes Singapore
Prof Jonathan Shaw
Deputy Director at Melbourne’s Baker Heart and Diabetes Institute
Dr Francis CC Chow
Consultant Endocrinologist & Honorary Associate Professor Department of Medicine & Therapeutics Prince of Wales Hospital The Chinese University of Hong Kong
 

Taking Diabetes to Heart: Value of Cardiovascular Biomarkers for your Diabetic Patients

 

 

Friday, 21st October 2022

13:30 – 14:30 (GMT +8)

View other time zones

At the heart of the discussion on diabetes, this webinar will discuss the importance of cardiovascular risk assessment for your type 2 diabetes mellitus patients. With the new tools on assessment, we will have a heart-to-heart talk with the experts and share how the biomarker keeps the beat.

Let’s register and find out during the webinar.

Faculty

Headshot of Dr Bee Yong Mong

Moderator

Dr Bee Yong Mong

Head and Senior Consultant, Department of Endocrinology, Singapore General Hospital Clinical Associate Professor, Duke-NUS Medical School

Read More

 

Headshot of Prof Jonathan Shaw

Speaker

Prof Jonathan Shaw

Deputy Director at Melbourne’s Baker Heart and Diabetes Institute

Read More

 

Headshot of Dr Francis CC Chow

Speaker

Dr Francis CC Chow

Consultant Endocrinologist & Honorary Associate Professor Department of Medicine & Therapeutics Prince of Wales Hospital The Chinese University of Hong Kong

Chairman & Managing Director, Hong Kong Diabetes Specialist Centre Hong Kong SAR

Read More

 

Who should attend:

Cardiologists, Diabetologists, Endocrinologists, GPs and Healthcare professionals interested in the topic

Key reasons to attend:

  • To learn about the cardiovascular disease and heart failure risks in diabetic patients
  • To understand the value of NT-proBNP in clinical use
  • To know the clinical approach of managing patients with elevated NT-proBNP
  • To be aware on the guidelines on usage of NT-proBNP
  • To hear from APAC Endocrinologist on real world clinical implementation of NT-proBNP in T2DM patients

Agenda

TIME

TOPIC

SPEAKERS


13:30 – 13:35
Welcome and Intro
Dr Bee Yong Mong

13:35 – 13:55
What and How: NT-proBNP as a tool for CVD risk assessment in T2DM
Dr Jonathan Shaw

13:55 – 14:15
Weaving NT-proBNP in real world clinical practice
Dr Francis Chow

14:15 – 14:30
Panel Discussion & Closing
All

Updates from Leading Experts

STRONG-HF: Post-discharge Heart Failure Management and Implementation of GDMT Heart Failure Therapy

Prof Alexandre Mebazaa shares the key results and highlights from the STRONG-HF study that assessed the safety, tolerability of optimization of guideline directed medical therapy.

28 March 2023
Prof Alexandre Mebazaa

CANVAS study: NT-proBNP and CVD risk reduction

Can you give us a short description of the CANVAS program? The CANVAS program was a set of two trials, whose goal was to evaluate the role of an SGLT2...

1 July 2021
Dr James L Januzzi